Sales drive up CogState revenues
Wednesday, 24 August, 2005
Melbourne-based neurodiagnostic specialist CogState (ASX:CGS) has reported revenues of AUD$1.5 million for the financial year ending June 30 2005, nearly three times more than the previous corresponding period, largely through sales to major pharmaceutical companies and research institutions.
The company recorded an increase in sales of its diagnostic product of 434 per cent, up from $192,094 in 2004 to $1 million in 2005.
Cogstate reported a net loss of $2.2 million and at 30 June 2005 had a cash balance of balance of $3.4 million.
Cartherics and Catalent announce enhanced partnership
To support immune cell therapy products for the treatment of cancer and endometriosis, Australian...
Alliance seeks to boost regional capacity in clinical trials
Launched this week, the Barwon Health–Deakin University Clinical Trials Alliance is...
Lipid science receives new Australia-led online hub
The Lipid Network launched this month to build links between researchers, clinicians and industry...
